Advanced search
Publication Cover
Drug Metabolism Reviews Volume 55, 2023 - Issue 1-2
Submit an article Journal homepage
281
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice

Miao Yana Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China;b Institute of Clinical Pharmacy, Central South University, Changsha, China;c International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, ChinaORCID Iconhttps://orcid.org/0000-0002-3582-8305View further author information
ORCID Icon,
Wenqun Lia Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China;b Institute of Clinical Pharmacy, Central South University, Changsha, China;c International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, ChinaView further author information
,
Wen-Bo Lid Department of Plastic and Aesthetic Surgery, The Second Xiangya Hospital, Central South University, Changsha, ChinaView further author information
,
Qi Huange Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, ChinaView further author information
,
Jing Lie Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, ChinaView further author information
,
Hua-Lin Caia Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China;b Institute of Clinical Pharmacy, Central South University, Changsha, China;c International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, ChinaView further author information
,
Hui Gonga Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China;b Institute of Clinical Pharmacy, Central South University, Changsha, China;c International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, ChinaView further author information
,
Bi-Kui Zhanga Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China;b Institute of Clinical Pharmacy, Central South University, Changsha, China;c International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, ChinaView further author information
&
Yi-Kun Wanga Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China;b Institute of Clinical Pharmacy, Central South University, Changsha, China;c International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 94-106 | Received 05 Sep 2022, Accepted 16 Nov 2022, Published online: 01 Dec 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ling Liu, Chengyi Zhang, Huihui Liu, Huan Luo, Rong Cao, Mingxuan Xiao, Pan Zou, Zhuzhu Xie, Hui Gong, Rui Ma, Miao Yan & Zhichao Jiang. (2024) Reporting of tumor lysis syndrome with targeted therapy for hepatic cancer in the FDA adverse events reporting system. Expert Opinion on Drug Safety 0:0, pages 1-7.
Read now
Abdelbaset A Elzagallaai & Michael J Rieder. (2023) Novel insights into molecular and cellular aspects of delayed drug hypersensitivity reactions. Expert Review of Clinical Pharmacology 16:12, pages 1187-1199.
Read now

Articles from other publishers (3)

Zhen Wang, Lili Jiang, Xin Lv, Hang Yin, Zhe Wang, Wenli Li & Yong Liu. (2024) Higher risk of hepatotoxicity associated with cabozantinib in cancer patients. Critical Reviews in Oncology/Hematology 196, pages 104298.
Crossref
Miaomiao Tang, Zhanxuan E. Wu & Fei Li. (2024) Integrating network pharmacology and drug side-effect data to explore mechanism of liver injury-induced by tyrosine kinase inhibitors. Computers in Biology and Medicine 170, pages 108040.
Crossref
Shuang Xia, Hui Gong, Yichang Zhao, Lin Guo, Yikun Wang, Rui Ma, Bikui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi & Miao Yan. (2023) Tumor Lysis Syndrome Associated with Monoclonal Antibodies in Patients with Multiple Myeloma: A Pharmacovigilance Study Based on the FAERS Database . Clinical Pharmacology & Therapeutics 114:1, pages 211-219.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.